Vivani Medical Inc. (VANI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vivani Medical Inc. (VANI) has a cash flow conversion efficiency ratio of -0.318x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.04 Million) by net assets ($18.97 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see VANI market cap for the company's overall valuation and market capitalisation.
Vivani Medical Inc. - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Vivani Medical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Vivani Medical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vivani Medical Inc. ranked by their cash flow conversion efficiency. Explore Vivani Medical Inc. cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
An Phat Plastic and Green Environment JSC
VN:AAA
|
0.021x |
|
Aroot Co. Ltd
KQ:096690
|
-0.026x |
|
ReaLy Development & Construction
TWO:2596
|
0.055x |
|
Macauto Industrial Co Ltd
TWO:9951
|
0.065x |
|
Aesler Grup Internasional Tbk Pt
JK:RONY
|
-1.290x |
|
Viva Leisure Ltd
AU:VVA
|
0.366x |
|
Kyung Nong Corporation
KO:002100
|
-0.087x |
|
Intertek Group PLC
LSE:ITRK
|
0.350x |
Annual Cash Flow Conversion Efficiency for Vivani Medical Inc. (2012–2025)
The table below shows the annual cash flow conversion efficiency of Vivani Medical Inc. from 2012 to 2025. View current stock price of Vivani Medical Inc. for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $15.73 Million | $-24.32 Million | -1.546x | -30.99% |
| 2024-12-31 | $17.61 Million | $-20.79 Million | -1.180x | -3.40% |
| 2023-12-31 | $20.76 Million | $-23.70 Million | -1.142x | -169.22% |
| 2022-12-31 | $44.31 Million | $-18.79 Million | -0.424x | +88.62% |
| 2021-12-31 | $2.46 Million | $-9.19 Million | -3.727x | +4.60% |
| 2020-12-31 | $1.95 Million | $-7.62 Million | -3.907x | -2.88% |
| 2019-12-31 | $7.28 Million | $-27.63 Million | -3.798x | +60.71% |
| 2018-12-31 | $3.08 Million | $-29.81 Million | -9.666x | -218.15% |
| 2017-12-31 | $7.88 Million | $-23.95 Million | -3.038x | -35.12% |
| 2016-12-31 | $11.15 Million | $-25.07 Million | -2.248x | -121.77% |
| 2015-12-31 | $20.27 Million | $-20.55 Million | -1.014x | -105.34% |
| 2014-12-31 | $34.62 Million | $-17.09 Million | -0.494x | -126.13% |
| 2013-12-31 | $-9.22 Million | $-17.43 Million | 1.890x | -62.45% |
| 2012-12-31 | $-3.04 Million | $-15.32 Million | 5.034x | -- |
About Vivani Medical Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the t… Read more